June 26, 2026 · Form 4 insider transaction
Feider Stephen sold 5,104 shares of Beta Bionics, Inc. at $17.05 per share, a transaction worth $87.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.; The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.